1-7 of 7
Petra Bělohlávková
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real World Population- Based Data from Nationwide Registry Support the Existence of Accelerated Phase in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients Even in Tyrosine Kinase Inhibitors (TKIs) Era

Tomas Hornak, Jiri Mayer, Petra Cicatkova, Lukas Semerad, Anezka Kvetkova, Hana Klamova, Edgar Faber, Petra Belohlavkova, Michal Karas, Lukas Stejskal, Eduard Cmunt, Olga Cerna, Dana Srbova, Hana Zizkova, Lucia Vrablova, Ivana Skoumalova, Jaroslava Voglova, Tereza Jurkova, Marika Chrapava, Tomas Jurcek, Ivana Jeziskova, Marie Jarosova, Katerina Machova Polakova, Tomas Papajik, Pavel Zak, Pavel Jindra, Daniela Zackova
Journal: Blood
Blood (2023) 142 (Supplement 1): 3166.
https://doi.org/10.1182/blood-2023-174455
Published: 2023
Journal Articles

Half: A Prospective Multi-Centre Phase II Clinical Trial Evaluating the Efficacy and Safety of Tyrosine Kinase Inhibitors' Discontinuation after Two-Step Dose Reduction in Patients with Chronic Myeloid Leukemia in Deep Molecular Remission

Daniela Žácková, Edgar Faber, Lukáš Stejskal, Michal Karas, Petra Bělohlávková, Hana Klamová, Olga Černá, Eduard Cmunt, Petra Čičátková, Lukáš Semerád, Tomáš Horňák, Anežka Kvetková, Jiřina Procházková, Jitka Rychlíčková, Radka Štěpánová, Adam Svobodník, Kateřina Machová Poláková, Ivana Ježíšková, Tomáš Jurček, Marek Borský, Ondřej Wiewiorka, Regina Demlová, Jiří Mayer
Journal: Blood
Blood (2021) 138 (Supplement 1): 3606.
https://doi.org/10.1182/blood-2021-146221
Published: 2021
Journal Articles

Ponatinib Treatment in CML and Ph+ ALL Patients: Real-Life Data from the Czech Registries

Eva Koriťáková, RNDr., PhD, Michael Doubek, MD PhD, Edgar Faber, MD PhD, Daniela Žáčková, MD PhD, Jan M. Horáček, MD PhD, Petra Bělohlávková, MD PhD, Eduard Cmunt, MD PhD, František Folber, MD PhD, Pavel Jindra, MD PhD, Hana Klamová, MD PhD, Zdeněk Kořístek, MD PhD, Lukáš Stejskal, MD, Tomáš Szotkowski, MD PhD, Cyril Šálek, MD PhD, Renata Kellnerová, MD PhD, Marika Chrápavá, Mgr.
Journal: Blood
Blood (2019) 134 (Supplement_1): 5905.
https://doi.org/10.1182/blood-2019-126395
Published: 2019
Journal Articles

Genotypes of the Gene Encoding the Membrane Transporter SLC22A4 Are Associated with Molecular Relapse-Free Survival after Discontinuation of Imatinib Therapy in Patients with Chronic Myeloid Leukemia

Katerina Machova, Ali Albeer, Vaclava Polivkova, Katerina Vlcanova, Alice Fabarius, PhD, Hana Klamová, MD PhD, Birgit Spiess, Cornelius Waller, Tim H Brümmendorf, MD, Jolanta Dengler, MD, Volker Kunzmann, MD PhD, Andreas Burchert, MD, Petra Bělohlávková, MD PhD, Satu Mustjoki, MD PhD, Edgar Faber, MD, Jiri Mayer, MD, Daniela Žáčková, MD PhD, Panayiotis Panayiotidis, MD, Johan Richter, MD PhD, Henrik Hjorth-Hansen, MD, Susanne Saussele, MD, Markus Pfirrmann, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1647.
https://doi.org/10.1182/blood-2019-129710
Published: 2019
Journal Articles

Comparison of Glucose and Lipid Metabolism Abnormality during Nilotinib, Imatinib and Dasatinib Therapy – Results of Enigma 2 Study

Racil Zdenek, Petra Belohlavkova, Petr Cetkovsky, Edgar Faber, Hana Klamova, Malaskova Ludmila, Tomasz Sacha, MD PhD, Voglova Jaroslava, Daniela Zackova, Pavel Zak, Jiri Mayer
Journal: Blood
Blood (2014) 124 (21): 1813.
https://doi.org/10.1182/blood.V124.21.1813.1813
Published: 2014
Journal Articles

New Mutation in ALAS2 as the Cause of X-Linked Sideroblastic Anemia Responsive to Pyridoxine: Comparison of ALAS2-Defective and DMT1-Defective BFU-E Growth.

Jana Kucerova, MSc, Monika Horvathova, MSc, PhD, Petra Belohlavkova, MD, Jaroslav Cermak, M.D., Ph.D., Vladimir Divoky, PhD
Journal: Blood
Blood (2009) 114 (22): 4051.
https://doi.org/10.1182/blood.V114.22.4051.4051
Published: 2009
Journal Articles

Successful Treatment with Imatinib Mesylate Significantly Decreases Plasma Levels of Vascular Endothelial Growth Factor (VEGF) and Soluble Endoglin (sCD105) but Not Basic Fibroblast Growth Factor (bFGF) or Angiopoietin-2 (Ang-2) in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase

Lukas Smolej, MD, PhD, Ctirad Andrys, M.S., Ph.D., Jaroslava Voglova, M.D., Petra Belohlavkova, M.D., Jana Rabasova, M.S., Martin Beranek, PharmDr. Ph.D., Jaroslav Maly, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 4252.
https://doi.org/10.1182/blood.V112.11.4252.4252
Published: 2008